Technology

Arcus Biosciences

$38.41
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.36 (+3.67%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell RCUS and other stocks, options, and ETFs commission-free!

About RCUS

Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. The firm competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA. The listed name for RCUS is Arcus Biosciences, Inc.

CEO
Terry J. Rosen
Employees
139
Headquarters
Hayward, California
Founded
2015
Market Cap
2.60B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
584.82K
High Today
$38.87
Low Today
$36.53
Open Price
$36.61
Volume
388.48K
52 Week High
$40.01
52 Week Low
$8.55

Collections

RCUS Earnings

-$0.93
-$0.60
-$0.28
$0.05
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 4, After Hours

You May Also Like

QMJ
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure